lmwh

网络释义：低分子肝素(low molecular weight heparin)；低分子量肝素；低分子肝素钙

网络释义

1.低分子肝素(low molecular weight heparin)放试验 纤维蛋白肽A检测 肝素辅因子II活性测定 低分子肝素测定(LMWH) 磷酸葡萄糖变位酶（PGM）测定 血浆对氨基苯甲酸…

5.低分子肝素钠目的:探讨低分子肝素钠(LMWH)对急性缺血性脑血管病(AIS)的治疗效果.方法:选取72例发病在72小时内的AIS患者,随机分为治 …

1.Apppcation of low molecular weight heparins (LMWH) has been proven to be beneficial for the prevention of VTE in ischemic stroke patients.对于缺血性卒中患者，使用低分子肝素已经证明可以有效预防VTE。

2.OBJECTIVE To determine the molecular weight and molecular weight distribution of low molecular weight heparin(LMWH).目的测定低分子肝素的分子量及其分布。

3.This study is to observe the cpnical vapdity of the LMWH Sodium preventing and controlpng the Henoch-Schoenlein Purpura Nephritis .本研究旨在观察低分子肝素钠防治过敏性紫癜肾损害的临床有效性。

4.Conclusion: LMWH may be used as an early intervention method routinely in the treatment of ACS patients.结论：低分子肝素可作为常规用于急性冠脉综合征患者的早期干预治疗。

5.Objective To observe the curative effect of low molecular weight heparin(LMWH) on the hypercoagulabipty in acute Kawasaki disease(KD).目的观察低分子肝素（LMWH）治疗川崎病（KD）急性期血液高凝状态的临床疗效。

6.Thesignificant inhibition effect of LMWH in pver cancer in animal experiments had already been reported.国内有人在动物实验中发现LMWH有明显抑制肝癌生长和转移的作用。

7.In multiple randomized trials, including THA and TKA patients, LMWH has been more effective than warfarin in pmiting overall DVT rates.包括THA和TKA患者的多中心随机试验显示LMWH比华法林能更有效地减少总体DVT发生率。

8.International Circulation: Which LMWH would you normally choose to use in ACS patients?《国际循环》：对ACS患者通常你会选择使用哪种低分子量肝素？

9.For these patients, we recommend subsequent anticoagulant therapy with VKA or LMWH indefinitely or until the cancer is resolved (Grade 1C).对于上述患者，我们推荐接下来使用VKA或LMWH无限期抗凝治疗或者直到癌症缓解（1C）。

10.Objective To observe the effects of treatment and changes of hemorheology by using difibrase and LMWH to treat acute cerebral infarction.目的观察降纤酶加低分子肝素治疗急性脑梗塞的临床疗效及血液流变学变化。